The study on the roles of cytoskeleton-associated protein 4 in atrial fibrosis of atrial fibrillation patients and prognosis of catheter ablation

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000038977

Enrollment

Unknown

Registered

2020-10-11

Start date

2021-01-01

Completion date

Unknown

Last updated

2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

Recurrence group and non recurrence group:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with symptomatic paroxysmal or persistent atrial fibrillation who failed to respond to drug therapy; 2. Patients aged 18 years or less and over 85 years old; 3. Patients who agreed to receive radiofrequency ablation for atrial fibrillation.

Exclusion criteria

Exclusion criteria: 1. Patients with thrombus in left atrium and left atrial appendage; 2. Patients with rheumatic heart disease: moderate to severe mitral stenosis; 3. Patients after mechanical mitral valve replacement; 4. Patients with severe bloodstream infection; 5. Patients with severe cardiac insufficiency (NYHA grade III-IV); 6. Patients with liver and kidney dysfunction.

Design outcomes

Primary

Measure	Time frame
CKAP4;CKAP4;	—

Countries

China

Contacts

Public ContactHongwei Tan

Tongji Hospital Affiliated to Tongji University

tanhongweikoui@126.com+86 15921630387

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026